Literature DB >> 24075483

Phenylboronic acid-functionalized polymeric micelles with a HepG2 cell targetability.

Xiaojin Zhang1, Zhenguo Zhang, Xin Su, Mengmeng Cai, Renxi Zhuo, Zhenlin Zhong.   

Abstract

Phenylboronic acid-functionalized amphiphilic block copolymer Pluronic-PMCC-BA was synthesized via ring-opening polymerization of 5-methyl-5-benzyloxycarbonyl-1,3-dioxan-2-one (MBC) with fumaric acid as a catalyst followed by the deprotection of carboxyl groups by catalyzed hydrogenation and the condensation of 3-aminophenylboronic acid with the copolymer side groups. Pluronic-PMCC-BA can form stable micelle solution by self-assembly in water. The phenylboronic acid groups are located at the shell of micelle as proved by (1)H NMR. The diameter of drug-free micelles is approximate 60 nm. Nano-spheres with narrow size distribution could be observed in the TEM image. MTT assay results show that Pluronic-PMCC-BA exhibits slight cytotoxicity when the polymer concentration is higher than 25 μg mL(-1). The toxicities of DOX@Pluronic-PMCC and DOX@Pluronic-PMCC-BA to COS7, HeLa, and HepG2 cell lines are similar with those of free DOX. Interestingly, phenylboronic acid groups located at the surface of Pluronic-PMCC-BA micelles can recognize HepG2 cells and promote the drug uptake of the cells, which are observed by confocal laser scanning microscopy (CLSM). The results imply that Pluronic-PMCC-BA would be a promising material for targeted drug delivery to the cancer cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Controlled drug release; Copolymer; Pluronics; Polycarbonate; Polymeric micelle

Mesh:

Substances:

Year:  2013        PMID: 24075483     DOI: 10.1016/j.biomaterials.2013.09.042

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  2 in total

1.  Development of phenylboronic acid-functionalized nanoparticles for emodin delivery.

Authors:  Bo Wang; Limin Chen; Yingjuan Sun; Youliang Zhu; Zhaoyan Sun; Tiezhu An; Yuhua Li; Yuan Lin; Daping Fan; Qian Wang
Journal:  J Mater Chem B       Date:  2015       Impact factor: 6.331

Review 2.  Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.

Authors:  Deidra M Ward; Aaliyah B Shodeinde; Nicholas A Peppas
Journal:  Adv Healthc Mater       Date:  2021-05-11       Impact factor: 11.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.